Sergio Traversa

Insider Reports History

Entity
Individual
Location
138 Canterbury Ln, Blue Bell, PA
Signature
/s/ Sergio Traversa
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sergio Traversa:

Stock Role Class Num Shares Value Price $ Report Date Ownership
RELMADA THERAPEUTICS, INC. Chief Executive Officer, Director Common Stock 384K $1.15M $2.99 Sep 11, 2024 Direct
RELMADA THERAPEUTICS, INC. Chief Executive Officer, Director Stock Option (right to buy) 184K May 24, 2024 Direct

Insider Reports Filed by Sergio Traversa

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RLMD RELMADA THERAPEUTICS, INC. Sep 9, 2024 3 $395K 4 Sep 11, 2024 Chief Executive Officer, Director
RLMD RELMADA THERAPEUTICS, INC. May 24, 2024 2 $0 4 May 29, 2024 Chief Executive Officer, Director
RLMD RELMADA THERAPEUTICS, INC. Jan 29, 2024 3 $387K 4 Jan 31, 2024 Chief Executive Officer, Director
RLMD RELMADA THERAPEUTICS, INC. Dec 15, 2023 1 $0 4 Dec 19, 2023 Chief Executive Officer, Director
RLMD RELMADA THERAPEUTICS, INC. May 25, 2023 1 $0 4 May 30, 2023 Chief Executive Officer, Director
RLMD RELMADA THERAPEUTICS, INC. Dec 31, 2022 7 $0 5/A Feb 6, 2023 CEO, Director
RLMD RELMADA THERAPEUTICS, INC. Dec 16, 2022 1 $0 4 Dec 20, 2022 Chief Executive Officer, Director
RLMD RELMADA THERAPEUTICS, INC. Dec 16, 2022 1 $0 4 Dec 20, 2022 Chief Executive Officer, Director
RLMD RELMADA THERAPEUTICS, INC. Dec 8, 2022 1 $116K 4 Dec 12, 2022 Chief Executive Officer, Director
RLMD RELMADA THERAPEUTICS, INC. Jun 30, 2022 9 -$83.3K 4 Jul 5, 2022 Chief Executive Officer, Director
RLMD RELMADA THERAPEUTICS, INC. May 25, 2022 2 $0 4 May 26, 2022 Chief Executive Officer, Director
RLMD RELMADA THERAPEUTICS, INC. Dec 17, 2021 1 $0 4 Dec 21, 2021 Chief Executive Officer, Director